Tag: CPAP
In brief: CPAP’s adherence assumption, CGM’s benefits, Shaq’s sleep apnea
June 12, 2026HME News Staff
ORLANDO, Fla. – Many insurers stop covering continuous positive airway pressure (CPAP) devices if patients don’t use them regularly in the first 90 days. But new research presented at the ATS 2026 International Conference shows that many patients who initially struggle to meet these early-use thresholds do go on to use and benefit from CPAP therapy.
The findings challenge long-held assumptions that poor early use predicts long-term CPAP use, said first author Dennis Hwang, MD, a sleep...
New research questions Medicare’s 90-day rule for CPAP adherence
June 11, 2026HME News Staff
ORLANDO, Fla. – Many insurers stop covering continuous positive airway pressure (CPAP) devices if patients don’t use them regularly in the first 90 days. But new research presented at the ATS 2026 International Conference shows that many patients who initially struggle to meet these early-use thresholds do go on to use and benefit from CPAP therapy.
The findings challenge long-held assumptions that poor early use predicts long-term CPAP use, said first author Dennis Hwang, MD, a sleep...
Sleep therapy growth at inflection point
June 10, 2026HME News Staff
Sleep therapy is expanding across new channels, technologies and care settings, creating more ways than ever to diagnose and treat obstructive sleep apnea – and giving providers new opportunities to shape the patient journey, despite its growing complexity, industry experts say.
“Demand remains strong because obstructive sleep apnea continues to be significantly underdiagnosed, but the pathway into therapy is changing rapidly,” said Robin Randolph, senior vice president of sales...
Philips continues to lean on international sleep growth, as FDA path continues
May 8, 2026Liz Beaulieu, Editor
AMSTERDAM – The Sleep and Respiratory Care (SRC) business at Philips grew in the low single digits in the first quarter of 2026, but its obstructive sleep apnea (OSA) portfolio stood out with double-digit growth outside of the U.S., says CEO Roy Jakobs.
International markets fuel OSA growth
OSA growth was particularly strong in Japan, the company’s second-largest market, Jakobs said during a recent conference call to discuss the company’s financial results.
“If you...
OIG: Medicare payments for CPAP ‘generally’ comply with billing rules
April 28, 2026HME News Staff
WASHINGTON - Medicare payments made to suppliers for PAP devices generally complied with Medicare billing requirements, according to a new report from the Office of Inspector General (OIG).
For fiscal year 2017, the Comprehensive Error Rate Testing (CERT) Program determined continuous PAP (CPAP) devices had the second highest improper payment amount in the DMEPOS category, with estimated improper payments totaling $495 million for CPAP devices used for the treatment of obstructive sleep apnea...
Viemed looks to sleep momentum, maternal health acquisition to fuel 2026
March 6, 2026Theresa Flaherty, Managing Editor
LAFAYETTE, La. – Viemed is forecasting “pretty aggressive” growth in its sleep business in the year ahead, driven by strong increases in new patient setups and a corresponding boost in its resupply business, say company execs.
During 2025, new sleep patient setups increased 70% and resupply sales increased 49% year-over-year, said CEO Casey Hoyt on a recent call to discuss the company’s fourth quarter and full year 2025 earnings.
“As the PAP base grows, more patients...
Bleep names technology expert to board
March 3, 2026HME News Staff
CHAPEL HILL, N.C. – Bleep LLC, maker of the Eclipse mask-less CPAP solution, has announced that Tom Beckley has joined the company's board of directors. Beckley is senior vice president of strategic technology programs at Cadence helping drive AI-enabled electronics and electro-mechanical development. Beckley has also held roles as head of the systems division at Avant! Corporation, president and CEO of Xynetix, and held engineering and management positions at L3Harris...
REMSleep plans ‘big push’ for DeltaWave in competitive CPAP mask market
February 6, 2026Liz Beaulieu, Editor
BLACKSHEAR, Ga. – REMSleep says the final pieces of its commercial strategy for the DeltaWave nasal pillow system are falling into place as the company prepares for a broader market push.
FDA clearance expands DeltaWave's use case
Most recently, REMSleep received expanded 510(k) clearance from the U.S. Food and Drug Administration (FDA) for DeltaWave to be used across care settings (home, hospitals, institutions and...
Resmed Q2: Mask sales surge as new products, resupply gain traction
January 30, 2026Liz Beaulieu, Editor
SAN DIEGO – Masks and accessories were the standout growth category for Resmed in the second quarter of its fiscal year 2026, with the company reporting a 16% increase in revenue in the United States, Canada and Latin America.
Even excluding revenue from VirtuOx, which Resmed acquired in the fourth quarter of 2025, the company still posted double-digit growth in mask revenue during the quarter, according to Chairman and CEO Mick Farrell,...
CPAP market still wide open, say poll respondents
January 23, 2026Liz Beaulieu, Editor
YARMOUTH, Maine – Nearly five years after the Philips Respironics recall reshaped the CPAP market, respondents to a recent HME Newspoll say there’s still significant opportunity for new competition and innovation.
Seventy‑two percent of respondents report they are currently looking to add new CPAP devices to their portfolios this year, and 45% say they are exploring new CPAP masks.
“We are in need of additional competitors and options, because the current...